There will be a price to pay for making vaccines too expensive

Few developing countries will be interested, for example, in the
vaccine produced by Moderna Inc., which requires the sort of
super-cooled storage facilities they would struggle to build.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/there-will-be-a-price-to-pay-for-making-vaccines-too-expensive/articleshow/79381348.cms

Comments

Popular posts from this blog

Sunday Worship Service

Teva Regulatory Affairs Associate Job Vacancy – Apply Online

Teva Regulatory Affairs Job Vacancy – Pharma Candidates Apply